분화갑상선암의 수술 전 병기진단: CT검사 필요한가? = Preoperative Staging of Well-Differentiated Thyroid Cancer: Is CT Needed?

다국어 초록 (Multilingual Abstract)

Ultrasound (US) is the essential primary imaging modality for preoperative staging of differentiated thyroid cancer. Although contrast-enhanced neck CT has been routinely used for the evaluation of general head and neck malignancy, routine use of contrast-enhanced CT is not recommended for the differentiated thyroid cancer by most international thyroid societies, and they recommend very conservative selective use of CT only for locally advanced thyroid cancers. This recommendation seems based on the fact that iodinated contrast media may interfere with radio-iodine treatment and the added value of CT has been little investigated.
Although the safety issue of CT contrast media is still controversial, the effect of CT contrast media on radio-iodine treatment seems not clinically significant if there is more than 2 month interval between intravascular administration of iodinated contrast media and radio-iodine treatment. Although CT has been widely used for preoperative evaluation of differentiated thyroid cancers in Korea, the added value of CT for detection of metastatic nodes has been little investigated. Compared with US, CT has advantages of less operator dependency and capability of scanning the whole neck. This suggests that CT may have complementary roles for detection of possible missing diagnosis of metastatic nodes by US and for detection of metastatic nodes at retropharyngeal area and low central neck (level 7 and low level 6 in some cases)which are not accessible by US. Because CT features of metastatic lymph nodes are different from those of US, combination of US and CT may have a potential to increase the diagnostic sensitivity for detection of metastatic cervical nodes. Recent studies suggest that CT may have a helpful complementary role for the evaluation of cervical metastatic nodes in differentiated thyroid carcinoma. However, added diagnostic value of CT and indication for CT use should be further investigated in the preoperative staging of differentiated thyroid carcinomas.

참고문헌 (Reference)

1 Schering, "ULTRAVISTⓇ. Annual report"

2 Mann K, "Systemic iodine absorptionduring endoscopic application of radiographic contrast agents for endoscopic retrograde cholangiopancreaticography" 130 (130): 498-501, 1994

3 Yi KH, "Revised Korean thyroid association management guidelines for patients with thyroid nodules and thyroid cancer" 3 (3): 65-96, 2010

4 Cooper DS, "Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer" 19 (19): 1167-1214, 2009

5 Choi JS, "Preoperative staging of papillary thyroid carcinoma: Comparison of ultrasound imaging and CT" 193 (193): 871-878, 2009

6 Kim E, "Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: Comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography" MARY ANN LIEBERT INC 18 (18): 411-418, 200804

7 Coel N, "Mechanism of radioactive iodine uptake depression following intravenous urography" 48 (48): 146-147, 1975

8 Spate VL, "Longitudinal study of iodine in toenails following IV administration of an iodinecontaining contrast agent" 236 : 71-76, 1998

9 Camargo R, "Latin American thyroid society recommendations for the management of thyroid nodules" 53 (53): 1167-1175, 2009

10 Chung YS, "Lateral lymph node metastasis in papillary thyroid carcinoma: Results of therapeutic lymph node dissection" 19 (19): 241-246, 2009

11 Nygaard B, "Iohexol: Effects on uptake of radioactive iodine in the thyroid and on thyroid function" 5 (5): 409-414, 1998

12 Costa A, "Iodine content of human tissues after administration of iodine containing drugs or contrast media" 1 (1): 221-225, 1978

13 Jeong HS, "Integrated 18F-FDG PET/CT for the initial evaluation of cervical node level of patients with papillary thyroid carcinoma: Comparison with ultrasound and contrast-enhanced CT" 65 (65): 402-407, 2006

14 Pacini F, "European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium" 154 (154): 787-803, 2006

15 Amdur RJ, "Essentials of thyroid cancer management" Springer 434-437, 2005

16 European Society of Urogenital Radiology, "ESUR guidelines on contrast media, version 6.0" 2007

17 Ahn JE, "Diagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer" 32 (32): 1552-1558, 2008

18 손규리, "Diagnostic Value of CT for the Detection of Cervical Lymph Node Metastases in Papillary Thyroid Carcinoma" 대한영상의학회 60 (60): 383-389, 2009

19 Yoon JH, "Contribution of computed tomography to ultrasound in predicting lateral lymph node metastasis in patients with papillary thyroid carcinoma" 2011

20 Laurie AJ, "Contrast material iodides: Potential effects on radioactive iodine thyroid uptake" 33 (33): 237-238, 1992

21 van der Molen AJ, "Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Effect of iodinated contrast media on thyroid function in adults" 14 (14): 902-907, 2004

22 Gharib H, "American association of clinical endocrinologists, associazione medici endocrinologi, and European thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules" 16 (16): 1-43, 2010

23 American college of radiology, "ACR practice guideline for the use of intravascular contrast media"